Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Rosiglitazone hydrochloride
Cat. No.:
OB0225LY-0357
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Add to basket
Product Overview
Description:
Rosiglitazone hydrochloride is a drug that selectively activates peroxisome proliferator-activated receptor gamma (PPAR-γ) and is mainly used to regulate glucose metabolism.
Synonym:
BRL-49653 HCl; Rosiglitazone HCl; 302543-62-0; Rosiglitazone (hydrochloride); 5-(4-(2-(Methyl(pyridin-2-yl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydrochloride
CAS No.:
302543-62-0
Compound CID:
9865387
Formula:
C18H19N3O3S·HCl
Formula Weight:
393.89
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Rosiglitazone hydrochloride can be used to study physiological processes related to the metabolic syndrome or play an important role in inflammatory response and insulin sensitivity studies.
Library Information
Targets:
PPAR family; TRP/TRPV channel
Receptors:
PPARγ1; PPARγ2; PPARγ; TRPC5; TRPM3
Pathways:
Apoptosis; Membrane transporter/Ion channel; Metabolism; DNA damage/DNA repair; Autophagy
Plate Number:
AOCL-5
Plate Location:
f2
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
73 mg/mL; 185.3 mM
Water Max Solubility:
<1 mg/mL (insoluble or slightly soluble)
Ethanol Max Solubility:
73 mg/mL; 185.3 mM
ALogP:
3.65
HBA_Count:
4
HBD_Count:
1
Rotatable Bond:
7
